Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Microbix Biosystms (TSE:MBX)
:MBX
MBX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.29 - C$0.55
Previous CloseN/A
Volume37.35K
Average Volume (3M)245.58K
Market Cap
C$64.55M
Enterprise ValueC$39.16M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)34.2
Beta-0.22
Next Earnings
May 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding134,477,050
10 Day Avg. Volume169,382
30 Day Avg. Volume245,577
Standard Deviation0.14
R-Squared0.00649
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.86
Price to Cash Flow (P/CF)20.80
P/FCF Ratio28.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.90Price Target Upside87.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Microbix Biosystms News
PremiumCompany Announcements
Microbix Engages Investors at Whistler Capital Event 2025PremiumCompany Announcements
Microbix Biosystems Earnings Call: Growth and Strategic Advances
PremiumCompany Announcements
Microbix Biosystems Achieves Strong Q1 Financial Performance
PremiumCompany Announcements
Microbix Biosystems to Release Q1 Fiscal 2025 Results and Host Webinar
PremiumCompany Announcements
Microbix Strengthens Financial Position with C$ 2.4 Million Equity Capital
PremiumCompany Announcements
Microbix and API Launch Pilot Program to Validate H5N1 DetectionPremiumCompany Announcements
Microbix Expands Market Reach with Recombinant Antigen Production
PremiumCompany Announcements
Microbix Biosystems Reports Record Revenue Growth---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMicrobix reported FY1Q-2025 financials beating Bloom Burton’s estimates.
Revenue GrowthAntigen revenues increased 118% Y/Y to $4.3M.
Bears Say
Revenue DeclineTotal revenues declined 28% Y/Y.
---
Options Prices
Currently, No data available
---
Ownership Overview
MBX FAQ
What was Microbix Biosystms’s price range in the past 12 months?
Microbix Biosystms lowest stock price was C$0.29 and its highest was C$0.55 in the past 12 months.
What is Microbix Biosystms’s market cap?
Microbix Biosystms’s market cap is C$64.55M.
When is Microbix Biosystms’s upcoming earnings report date?
Microbix Biosystms’s upcoming earnings report date is May 14, 2025 which is in 80 days.
How were Microbix Biosystms’s earnings last quarter?
Microbix Biosystms released its earnings results on Feb 13, 2025. The company reported C$0.006 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.006.
Is Microbix Biosystms overvalued?
According to Wall Street analysts Microbix Biosystms’s price is currently Undervalued.
Does Microbix Biosystms pay dividends?
Microbix Biosystms does not currently pay dividends.
What is Microbix Biosystms’s EPS estimate?
Microbix Biosystms’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Microbix Biosystms have?
Microbix Biosystms has 134,477,050 shares outstanding.
What happened to Microbix Biosystms’s price movement after its last earnings report?
Microbix Biosystms reported an EPS of C$0.006 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Microbix Biosystms?
Currently, no hedge funds are holding shares in TSE:MBX
---
Microbix Biosystms Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$0.90 (87.50% Upside)
C$0.90 (87.50% Upside)
Insider Transactions
Sold Shares
Worth C$586.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.25%
12-Months-Change
Fundamentals
Return on Equity
6.85%
Trailing 12-Months
Asset Growth
7.06%
Trailing 12-Months
Company Description
Microbix Biosystms
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company operates in two industries: the development, manufacturing, and distribution of cell-based products and technology and, the provision of the facility, technical and production personnel for contract research and development. Microbix operates in three principal geographical areas: North America, Europe and in other foreign countries. It derives most of its revenue from Europe.
---
MBX Stock 12 Month Forecast
Average Price Target
C$0.90
▲(87.50% Upside)
Technical Analysis
Biome Grow Inc
―
THC Biomed INTL
―
HLS Therapeutics Inc
―
Premier Health of America Inc
―
Best Analysts Covering MBX
1 Year
1 Year Success Rate
5/6 ratings generated profit
1 Year Average Return
+21.95%
reiterated a buy rating 9 days ago
Copying David Martin PhD's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.95% per trade.
---